Latest Stents News

'American Idol' Winner Undergoes Surgeries During ContestBy Celebrity Diagnosis We all know that "American Idol" can be a grueling experience for its contestants. But imagine undergoing eight surgical procedures over the course of it... We were aware that Season 11 winner Philip Phillips had bee...

Medtronic Resolute® Stent Shows Strong Performance in Heart Disease Patients With and Without DiabetesAccording to study results to be featured in Sunday’s late-breaking clinical trials session at the American Association of Clinical Endocrinologists (AACE) 21st Annual Scientific and Clinical Congress in Philadelphia, the Resolute® drug-eluting stent (DES) from Medtronic, Inc. (NYSE:MDT) yields strong performance in coronary artery disease (CAD) patient...

Stent Deployment Damage May Trigger AEs(MedPage Today) -- Balloon expansion of drug-eluting stents can result in polymer surface damage and microparticle detachment, which may contributed to DES-related adverse events, including stent thrombosis.

Biotronik reports six-month results of Pulsar stent systemBiotronik has reported positive six-month results of Pulsar stent system form 4EVER clinical study.

InspireMD Announces Enrollment Completion In Master TrialTEL AVIV, Israel, May 24, 2012 /PRNewswire/ -- InspireMD, Inc. (OTC BB: NSPR) (the "Company" or "InspireMD"), a medical device company focusing on the development and commercialization of its proprietary stent platform technology for use in patients with Acute Myocardial Infarctions, today announced that is has completed enrollment in the MASTER (MGuard™ for Acute ST...

Positive Results for Pulsar Stent in Clinical Study – BIOTRONIK announcesThe six-month results from the prospective, multicenter, single-arm 4EVER study demonstrate efficacy and safety of BIOTRONIK's Pulsar Stent System in 120 superficial femoral artery (SFA) patients. Analysis of the 120 patients showed excellent device...

First bedside DNA test to be introduced in Middle EastSpartan Bioscience announces DELTA as exclusive distributor for Middle East Ottawa, Ontario (PRWEB) May 24, 2012 Spartan Bioscience today announced exclusive agreements with DELTA Trading & Development for distribution of the first bedside DNA test in the Middle East. The agreements cover Bahrain, Egypt, Kuwait, Oman, Qatar, Saudi Arabia, Sudan, and United Arab Emirates. DELTA specializes in...

Stroke Devices: Innovation Drives GrowthInnovation is driving double-digit growth in the neurointerventional device market as an increasing number of medical device manufacturers develop newer, more effective devices for treating acute ischemic stroke. As new, stent-like retrieval systems...

Transcatheter Technologies GMBHA major limitation of existing transcatheter aortic heart valves is that they are unable to be repositioned once implanted. For these devices, the valve is mounted in a metal stent that contains a balloon, which is inflated once the valve is placed.

Tryton Announces Positive Clinical Data from More Than 900 Patients Treated with Its Bifurcation Stent System at EuroPCR 2012Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced results of a patient-level pooled analysis of six-month clinical outcomes of the TRYTON Side Branch Stent. Findings were presented last week in Paris at EuroPCR, the official congress of the European Association of Percutaneous Cardiova...

ERI Institute Launches Custom Product Brief Service for Hospitals and Health PlansNew concise, evidence-based reports help healthcare decision makers choose products wisely PLYMOUTH MEETING, Pa., May 23, 2012 /PRNewswire-USNewswire/ -- When healthcare value-analysis professionals are faced with manufacturer claims intended to convince them to purchase healthcare technologies and products, they ask, "Is there evidence to support the claims about this product—and t...

BIOTRONIK Announces Positive Results for Pulsar Stent in 4EVER Clinical Study BUELACH, SWITZERLAND -- (Marketwire) -- 05/23/12 -- The six-month results from the prospective, multicenter, single-arm 4EVER study demonstrate efficacy and safety of BIOTRONIK's Pulsar Stent System in 120 superficial femoral artery (SFA) patients. Analysis of the 120 patients showed excellent device performance, very promising patency rates and convincing evidence of the benefits of lower limb...

Nanotechnology In Brain Treatment ResearchResearchers at Purdue University are working with the U.S. Army and neurosurgeons at the Walter Reed National Military Medical Center to create a new type of "bioactive" coating for stents used to treat brain aneurisms including those caused by head...

Cook Medical introduces Zilver drug-eluting stent in AustraliaCook Medical has introduced Zilver PTX drug-eluting peripheral stent in Australia to treat patients with lesions in the superficial femoral artery.

Accumetrics Sees Significantly Increased Interest in VerifyNow P2Y12 Test as Plavix® Loses Patent ProtectionAccumetrics Inc., developer of the VerifyNow® System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, today announced that the introduction of multiple, new generic versions of clopidogrel into the US market has led to increased interest in platelet reactivity testing. In addition to...

UPDATE 2-Medtronic earnings rise, shares slipMay 22 (Reuters) - Medtronic Inc reported higher quarterly earnings on Tuesday as stronger sales of heart stents and insulin pumps offset lower demand for implantable heart defibrillators and spinal products.

Medtronic posts increase in Q4 revenue Medical technology company Medtronic (NYSE:MDT) increased revenues in its final quarter driven by steady progress at its cardiac and vascular businesses. Overall, revenue rose 4 per cent to US$4.3 billion in the quarter ended April 27,...

Researchers to create new type of bioactive coating for brain aneurysm stentsResearchers at Purdue University are working with the U.S. Army and neurosurgeons at the Walter Reed National Military Medical Center to create a new type of "bioactive" coating for stents used to treat brain aneurysms including those caused by head...

BIOTRONIK Announces Positive Results for Pantera Lux Paclitaxel Releasing Balloon in both Diabetic and Nondiabetic SubgroupsSix-month results from the DELUX registry demonstrating excellent safety and efficacy results for the Pantera Lux Paclitaxel Releasing Balloon in more than 1000 patients were presented by

Latest addition to Cook Medical's Leg Therapies product line, Zilver @ PTX @ Drug-Eluting Peripheral Stent, is designed to treat PAD in the superficial femoral artery (SFA)Latest addition to Cook Medical's Leg Therapies product line, Zilver @ PTX @ Drug-Eluting Peripheral Stent, is designed to treat PAD in the superficial femoral artery (SFA) BLOOMINGTON, Ind.--(BUSINESS WIRE)--May 21, 2012-- Cook Medical, a world le...

Cook Medical Launches First Drug-Eluting Stent in Australia to Treat Peripheral Arterial Disease (PAD)Cook Medical, a world leader in minimally invasive medical technologies, has launched a first-of-its-kind drug-eluting peripheral stent in Australia, the Zilver® PTX® Drug-Eluting Peripheral Stent. The device, which is available in more than 50 countries, is registered with Australia’s Therapeutic Goods Administration (TGA) and is now available...

W. L. Gore & Associates, Inc. (Gore) Announces Extension of Distribution Agreement with ConMed Corporation (ConMed) for the GORE® VIABIL® Biliary EndoprosthesisW. L. Gore & Associates, Inc. (Gore) today announced that it has extended its distribution agreement in the US and Canada with ConMed Endoscopic Technologies for the distribution and marketing of its

Cook Medical introduces drug-eluting peripheral stent to treat lesions in the SFACook Medical, a world leader in minimally invasive medical technologies, has launched a first-of-its-kind drug-eluting peripheral stent in Australia, the Zilver PTX Drug-Eluting Peripheral Stent.

Boston Scientific presents two-year Platinum Small Vessel study resultsBoston Scientific has presented two-year results of 2.25 mm Promus Element Everolimus-Eluting Platinum Chromium (PtCr) Stent system from the Platinum Small Vessel study.

Purdue professor to speak before Congress about nanotechnology in brain treatment research(Purdue University) Researchers at Purdue University are working with the US Army and neurosurgeons at the Walter Reed National Military Medical Center to create a new type of "bioactive" coating for stents used to treat brain aneurisms including tho...

0 1 2 3 4 ›»

buy Stents market research data and corporate reports now Advertisement